Comparative sequencing and association studies of aromatic L-amino acid decarboxylase in schizophrenia and bipolar disorder

Molecular Psychiatry

Volumn 5, Issue 3, 2000, Pages 327-331

  Speight, G ^a   Turic, D ^a   Austin, J ^b   Hoogendoorn, B ^a   Cardno, A G ^c   Jones, L ^a   Murphy, K C ^b   Sanders, R ^b   McCarthy, G ^c   Jones, I ^a   McCandless, F ^c   McGuffin, P ^a   Craddock, N ^a   Owen, M J ^b   Buckland, P ^c   O'Donovan, M C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

DDC; Gene; Mutation; Polymorphism; Psychosis

Indexed keywords

AMINO ACID DECARBOXYLASE; AROMATIC AMINO ACID; DOPAMINE; NEUROTRANSMITTER; PHENETHYLAMINE; SEROTONIN;

ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; SCHIZOPHRENIA;

EID: 0033938328     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000717     Document Type: Article

References (20)

1. Berry MD, Juorio AV, Li X-M, Boulton AA. Aromatic L-amino acid decarboxylase: a neglected and misunderstood enzyme. Neurochem Res 1996; 21: 1075-1087.
2. Buckland PR, Spurlock G, McGuffin P. Amphetamine and vjgabatrin down regulate aromatic L-amino acid decarboxylase mRNA levels. Brain Res Mol Brain Res 1996; 33: 69-76.
3. Underbill PA, Jin L, Lin AA, Mehdi SQ, Jenkins T, Vollrath D et al. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high performance liquid chromatography (DHPLC). Genome Res 1997; 7: 996-1005.
4. Sandier M, Reynolds GP. Does phenylethylamine cause schizophrenia? Lancet 1976; 1: 70-71.
5. Davis BA, Shrikande S, Paralikar VP, Hirsch SR, Durden DA, Boulton AA. Phenylacetic acid in CSF and serum in Indian schizo-phrenic patients. Prog Ncuropsychopharmacol Biol Psychiatry 1991; 15: 41-47.
6. O'Reilly R, Davis BA, Durden DA, Thorpe L, Machnee H, Boulton AA. Plasma phenylethylamine in schizophrenic patients. Biol Psychiatry 1991; 30: 145-150.
7. Reith J, Benkelfat C, Shenvin A, Yasuhara Y, Kmvabara H, Andermann F et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc NatI Acad Sei USA 1994; 01: 11651-11654.
8. Buckland PR, O'Donovan MC, McGuffin P. Changes in dopa decarboxylase mRNA but not tyrosine hydroxylase mRNA levels in rat brain following antipsychotic treatment. Psychopharmacology 1992; 108: 98-102.
9. Buckland PR, Marshall R, Watkins P, McGuffin P. Does phenylethylamine have a role in schizophrenia? LSD and PCP up-regulate aromatic L-amino acid decarboxylase mRNA levels. Brain Res Mol Brain Res 1997; 49: 266-270.
10. Sobell JL, Heston LL, Sommer SS. Delineation of genetic predisposition to multifactorial disease: a general approach on the threshold of feasibility. Genomics 1992; 12: 1-6.
11. Sumi-lchinose C, Ichinose H, Takahashi E, Hori T, Nagatsu T. Molecular cloning of gcnomic and chromosomal assignment of the gene for human aromatic L-amino acid decarboxylase, the enzyme for catecholamine and serotonin biosynthesis. Biochemistry 1992; 31: 2229-2238.
12. Chireux M, Raynal JF, Le Van Thai A, Cadas H, Bernard C, Martinou I et al. Multiple promoters of human choline acetyltransferase and aromatic L-amino acid decarboxylase genes. / Physiol Paris 1994; 88: 215-227.
13. O'Donovan MC, Ocfner PJ, Roberts SC, Austin J, Hoogendoorn B, Guy G et al. Blind analysis of denaturing high performance liquid chromatography as a tool for mutation detection. Genomics 199852: 44-49.
14. Jones A, Austin J, Hansen N, Hoogendoorn B, Oefner PJ, Cheadle JP et al. Optimal temperature selection for mutation detection by denaturing HPLC and comparison to single-stranded conformation polymorphism and heteroduplex analysis, din Chem 1999; 45: 1133-1140.
15. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edition). American Psychiatric Association: Washington DC, 1994.
16. IG McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCR1T system. Arch Gen Psychiatry 1991; 48: 764-770.
17. Wing JK, Cooper JE, Sartorius N. Measurement and Classification of Psychiatric Symptoms. Cambridge University Press: Cambridge, 1972.
18. Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R et al. SCAN: Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry 1990; 47: 589-593.
19. Owen MJ, Holmans P, McGuffin P. Association studies in psychiatric genetics. Mol Psychiatry 1997; 2: 270-273.
20. O'Donovan MC, Guy C, Craddock N, Bowen T, McKeon P, Macedo A et al. Confirmation of association between expanded CAG/CTG repeats and both schizophrenia and bipolar disorder. Psychol Med 1996; 2C: 1145-1153.